Molekulare diagnostische Methoden zur Erkennung interstitieller Lungenerkrankungen

Méthodes moleculaires de la diagnose des maladies interstice du pumon

Molecular methods for diagnosing interstitial lung diseases

Abstract

The present invention relates to molecular methods diagnosing interstitial lung diseases using arrays of candidate polynucleotides and to methods useful in molecular evaluation of the efficacy of a drug applied to a person in need suffering from an interstitial lung disease by gene expression profiling images.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (3)

    Publication numberPublication dateAssigneeTitle
    US-2002086289-A1July 04, 2002Don StrausGenomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
    US-5491062-AFebruary 13, 1996StratagenePolynucleotide amplification mycoplasma assay, primers, and kits therefore
    WO-0017391-A1March 30, 2000Innogenetics N.V.Identification of microorganisms causing acute respiratory tract infections (ari)

NO-Patent Citations (4)

    Title
    "GeneChip Human Genome U133 Set" AFFYMETRIX, XP002232760 Retrieved from the Internet: [retrieved on 2003-02-26]
    KAMINSKI NAFTALI ET AL: "Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 97, no. 4, 15 February 2000 (2000-02-15), pages 1778-1783, XP002237872 Feb. 15, 2000 ISSN: 0027-8424
    KATSUMA SUSUMU ET AL: "Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling." BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 288, no. 4, 9 November 2001 (2001-11-09), pages 747-751, XP002237871 ISSN: 0006-291X
    ZIESCHE R ET AL: "A PRELIMINARY STUDY OF LONG-TERM TREATMENT WITH INTERFERON GAMMA-1B AND LOW-DOSE PREDNISOLONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS" NEW ENGLAND JOURNAL OF MEDICINE, THE, MASSACHUSETTS MEDICAL SOCIETY, WALTHAM, MA, US, vol. 341, no. 17, 21 October 1996 (1996-10-21), pages 1264-1269, XP001145933 ISSN: 0028-4793

Cited By (15)

    Publication numberPublication dateAssigneeTitle
    CN-105247075-AJanuary 13, 2016维拉赛特股份有限公司Biomarkers for diagnosis of lung diseases and methods of use thereof
    EP-2971128-A4February 22, 2017Veracyte IncBiomarker zur diagnose von lungenerkrankungen und verfahren zur verwendung davon
    US-8450275-B2May 28, 2013Baxter International Inc., Baxter Healthcare SaTFPI inhibitors and methods of use
    US-8466108-B2June 18, 2013Baxter International Inc., Baxter Healthcare SaTFPI inhibitors and methods of use
    US-8673565-B2March 18, 2014National Jewish HealthMethods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
    US-8962563-B2February 24, 2015Baxter International, Inc., Baxter Healthcare SaTFPI inhibitors and methods of use
    US-9018167-B2April 28, 2015Baxter International Inc., Baxter Healthcare SaTFPI inhibitors and methods of use
    US-9556230-B2January 31, 2017Baxalta GmbH, Baxalta IncorporatedTFPI inhibitors and methods of use
    US-9777051-B2October 03, 2017Baxalta GmbH, Baxalta IncorporatedTFPI inhibitors and methods of use
    US-9873720-B2January 23, 2018Baxalta GmbH, Baxalta IncorporatedTFPI inhibitors and methods of use
    WO-2006039819-A1April 20, 2006St. Michael's HospitalMarqueurs de la lesion pulmonaire
    WO-2009034562-A2March 19, 2009Dublin City UniversityMethode permettant d'evaluer le risque de cancer chez un patient
    WO-2009034562-A3July 02, 2009Univ Dublin City, Paul Dowling, Martin Clynes, John Crown, Michael MoriartyMethode permettant d'evaluer le risque de cancer chez un patient
    WO-2009073167-A2June 11, 2009The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesIdentification et diagnostic de la fibrose pulmonaire au moyen de gènes de mucines, et procédés et compositions apparentés
    WO-2009073167-A3September 03, 2009The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human ServicesIdentification and diagnosis of pulmonary fibrosis using mucin genes, and related methods and compositions